The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
AACR 2021 | Emerging targeted agents in the field of mastocytosis
Tracy George, MD, The University of Utah, Salt Lake City, UT, outlines the current treatment landscape of systemic mastocytosis as well as emerging agents in this field, including novel anti-KIT approaches currently in evaluation in this patient population. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.
Disclosures
Tracy George, MD, has served as a consultant for Blueprint Medicines Corporation.
